Global Oral Vaccine Market, By Type (Live Attenuated, Recombinant, Inactive, Others), Product Type (Oral Polio Vaccine, Cholera Vaccine, Rotavirus Vaccine, Others), Application (Polio, Tuberculosis, Rabies, Influenza, Cholera, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Oral Vaccine Market
Oral vaccine market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 7.20% in the above mentioned forecast period.
Vaccines are the biologically prepared products that provide active acquired immunity to the diseases such as rotavirus, cholera, yellow fever polio, smallpox and others. The vaccines are developed from the love attenuated or the killed form of the diseases. Oral vaccines are safe, convenient for all age groups and easy to administer. These vaccines are developed to protect from various infectious diseases that are acquired through oral transmission.
Rise in the prevalence of infectious disease in developing countries, elimination of needles in the vaccination process, safe and cost effective nature of vaccines, growing funding by government and private organisations for vaccine development resistance to existing vaccines and bioterrorism are the factors that will expand the oral vaccine market.
Rise in the research and development activities and identifying the growing demands as well as new technology will provide beneficial opportunities for the oral vaccine market in the forecast period of 2021-2028.
However, high cost of vaccine development and storage and less effectiveness of oral vaccines as compared to vaccines that are administered through parenteral routes are the factors that will hinder the market growth and will further challenge the oral vaccine market in the forecast period mentioned above.
This oral vaccine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the oral vaccine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Oral Vaccine Market Scope and Market Size
The oral vaccine market is segmented on the basis of type, product type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the oral vaccine market is segmented into live attenuated, recombinant, inactive and others.
- On the basis of product type, the oral vaccine market is segmented into oral polio vaccine, cholera vaccine, rotavirus vaccine and others.
- On the basis of application, the oral vaccine market is segmented into polio, tuberculosis, rabies, influenza, cholera and others.
- On the basis of end-users, the oral vaccine market is segmented into clinic, hospital and others.
The oral vaccine market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Oral Vaccine Market Country Level Analysis
Oral vaccine market is analyzed and market size information is provided by the country, type, product type, application, end-users and distribution channel as referenced above.
The countries covered in the oral vaccine market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the oral vaccine market due to the presence of major key players, high purchasing power of region’s population to afford costly vaccine, the periodical mass immunization programs held by the government and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing incidence of influenza and HIV, rising investment in the healthcare sector and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Oral vaccine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Oral Vaccine Market Share Analysis
Oral vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global oral vaccine market research.
The major players covered in the oral vaccine market report are Merck Sharp & Dohme Corp., GlaxoSmithKline plc, Sanofi, Serum Institute of India Pvt. Ltd., Shanghai BravoBio Co., Ltd., Valneva Canada Inc., Immunitor, Inc., BB - NCIPD Ltd., Vaxart, Inc., Shantha Biotechnics, Johnson & Johnson Private Limited, Bibcol, VabioTech by Eternity, EUBIOLOGICS CO., LTD., Panacea Biotec Ltd., BIO-MED, HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-